{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:28:42Z","timestamp":1778743722116,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014088","name":"AstraZeneca France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cjca.2023.08.028","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:56:35Z","timestamp":1693716995000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["P2Y12 Inhibitor Loading Time Before Elective PCI and the Prevention of Myocardial Necrosis"],"prefix":"10.1016","volume":"40","author":[{"given":"Vincent","family":"Roule","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Beygui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Cayla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9goire","family":"Rang\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Motovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Delarche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Jourda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Goube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Guedeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Zeitouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"El Kasty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Laredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00eblle","family":"Dumaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Ducrocq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Derimay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Van Belle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Manigold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Cador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Combaret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-6809","authenticated-orcid":false,"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanne","family":"Silvain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.08.028_bib1","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.08.028_bib2","first-page":"S79","article-title":"The evolution of antiplatelet therapy after percutaneous coronary interventions: a 40-year journey","volume":"38","author":"Marquis-Gravel","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.08.028_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2005.10.047","article-title":"Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention","volume":"47","author":"Steinhubl","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.08.028_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ahj.2006.10.030","article-title":"Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort","volume":"153","author":"Sz\u00fck","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2023.08.028_bib5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2012.50788","article-title":"Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"308","author":"Bellemain-Appaix","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.08.028_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2010.01.067","volume":"56","author":"Di Sciascio","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.08.028_bib7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehn169","article-title":"Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8","volume":"29","author":"Widimsky","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.08.028_bib8","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jacc.2004.08.060","article-title":"Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization","volume":"44","author":"Kandzari","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.08.028_bib9","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(20)32236-4","article-title":"Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial","volume":"396","author":"Silvain","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.08.028_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/eurheartj\/ehaa885","article-title":"Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data","volume":"42","author":"Silvain","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.08.028_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","article-title":"Periprocedural myocardial infarction and injury in elective coronary stenting","volume":"39","author":"Zeitouni","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.08.028_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2020.04.017","article-title":"Blunting periprocedural myocardial necrosis: rationale and design of the randomized ALPHEUS study","volume":"225","author":"Silvain","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2023.08.028_bib13","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.08.028_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.08.028_bib15","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.08.028_bib16","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2006.06.065","article-title":"Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement","volume":"48","author":"Hochholzer","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.08.028_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcin.2011.03.002","article-title":"High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2)","volume":"4","author":"Collet","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.08.028_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.108.776757","article-title":"Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study","volume":"118","author":"Collet","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.08.028_bib19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jcin.2008.09.005","article-title":"The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the PRINC (Plavix Response in Coronary Intervention) trial","volume":"1","author":"Gladding","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.08.028_bib20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jacc.2007.12.013","article-title":"Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study","volume":"51","author":"L'Allier","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.08.028_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2006.04.090","volume":"48","author":"Montalescot","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.08.028_bib22","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.08.028_bib23","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.0000160869.75810.98","article-title":"Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention","volume":"111","author":"Hochholzer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.08.028_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/CIRCULATIONAHA.115.020829","article-title":"Consistent reduction in periprocedural myocardial infarction with cangrelor as assessed by multiple definitions: findings from CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)","volume":"134","author":"Cavender","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.08.028_bib25","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.CIR.0000157138.02645.11","article-title":"Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study","volume":"111","author":"Gurbel","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.08.028_bib26","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000161383.06692.D4","volume":"111","author":"Patti","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.08.028_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008649","article-title":"randomized comparison of intensified and standard p2y(12)-receptor-inhibition before elective percutaneous coronary intervention: the SASSICAIA trial","volume":"13","author":"Mehilli","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.08.028_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40256-015-0145-0","article-title":"Intravenous clopidogrel (MDCO-157) compared with oral clopidogrel: the randomized cross-over AMPHORE study","volume":"16","author":"Collet","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.cjca.2023.08.028_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.thromres.2016.10.013","article-title":"Chewed ticagrelor tablets provide faster platelet inhibition compared to integral tablets: the inhibition of platelet aggregation after administration of three different ticagrelor formulations (IPAAD-Tica) study, a randomised controlled trial","volume":"149","author":"Venetsanos","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2023.08.028_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1540-8183.2009.00475.x","article-title":"Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tablets","volume":"22","author":"Zafar","year":"2009","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.cjca.2023.08.028_bib31","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/CIRCULATIONAHA.120.051532","article-title":"Effect of prehospital crushed prasugrel tablets in patients with st-segment-elevation myocardial infarction planned for primary percutaneous coronary intervention: the randomized COMPARE CRUSH trial","volume":"142","author":"Vlachojannis","year":"2020","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23016471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23016471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:53:17Z","timestamp":1760107997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23016471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0828282X23016471"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.08.028","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y12 Inhibitor Loading Time Before Elective PCI and the Prevention of Myocardial Necrosis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}